Proteolytic Enzymes
On sale on the US market (according to the DSLD)
Doctor's Best, food supplement from the US market
Proteolytic Enzymes (Doctor's Best), a food supplement au code-barres 753950001848, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00692.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Doctor's Best
- Barcode
- 753950001848
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Hypromellose, Pectin, Water, Purified
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proteolytic Enzyme Blend | Blend | not stated |
| Bromelain | Enzyme | not stated |
| Papain | Enzyme | not stated |
| Amylase | Enzyme | not stated |
| Lipase | Enzyme | not stated |
| Neutral Protease | Enzyme | not stated |
| Protease, Fungal | Enzyme | not stated |
| Protease, Bacterial | Enzyme | not stated |
| Rutin | Other substance | 30 mg |
| Serratiopeptidase | Enzyme | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Proteolytic Enzymes
Entered into DSLD on 28 May 2019. Withdrawn from the US market on 16 December 2022 (according to the DSLD).- Active ingredient removed : Proteolytic Enzyme Blend (quantity not stated)
Official label: Proteolytic Enzymes
Entered into DSLD on 22 December 2017. Withdrawn from the US market on 11 December 2018 (according to the DSLD).- Active ingredient removed : Proteolytic Enzyme Blend (quantity not stated)
Official label: Best Proteolytic Enzymes
Entered into DSLD on 21 November 2016. Withdrawn from the US market on 20 October 2017 (according to the DSLD).- Active ingredient removed : Proteolytic Enzyme Blend (quantity not stated)
Official label: Best Proteolytic Enzymes
Entered into DSLD on 23 August 2013. Withdrawn from the US market on 2 May 2016 (according to the DSLD).- Active ingredient removed : Proteolytic Enzyme Blend (quantity not stated)
- Different unit, without conversion : Amylase: 36,000 DU in this version; quantity not stated on the displayed label
- Different unit, without conversion : Bromelain: 576 GDU in this version; quantity not stated on the displayed label
- Different unit, without conversion : Lipase: 405 FCC FIP in this version; quantity not stated on the displayed label
- Different unit, without conversion : Neutral Protease: 738 NU in this version; quantity not stated on the displayed label
- Different unit, without conversion : Papain: 10,077,000 PU in this version; quantity not stated on the displayed label
- Different unit, without conversion : Protease, Bacterial: 62,250 HUT in this version; quantity not stated on the displayed label
- Different unit, without conversion : Protease, Fungal: 34,800 HUT in this version; quantity not stated on the displayed label
- Different unit, without conversion : Serratiopeptidase: 120,000 SPU in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Rutin
Read the warning, when it applies and the studies cited
RUTIN
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).
Sources cited by Health Canada (1)
- PDR 2008: Hendler SS, Rorvik D. PDR for Nutritional Supplements. 2nd edition. Montvale (NJ): Thomson Healthcare; 2008.
- Serratiopeptidase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
Sources cited by Health Canada (1)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Doctor's Best
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Proteolytic Enzymes (Doctor's Best): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/753950001848-proteolytic-enzymes-doctor-s-best, updated 14 December 2023.